Therapy Discontinuation after Myocardial Infarction

被引:7
|
作者
Pietrzykowski, Lukasz [1 ]
Kasprzak, Michal [2 ]
Michalski, Piotr [1 ]
Kosobucka, Agata [1 ]
Fabiszak, Tomasz [2 ]
Kubica, Aldona [1 ]
机构
[1] Nicolaus Copernicus Univ, Coll Med, Dept Hlth Promot, M Curie Sklodowskiej 9 St, PL-85094 Bydgoszcz, Poland
[2] Nicolaus Copernicus Univ, Coll Med, Dept Cardiol, M Curie Sklodowskiej 9 St, PL-85094 Bydgoszcz, Poland
关键词
adherence; myocardial infarction; angiotensin converting enzyme inhibitors (ACEI); P2Y(12) receptor inhibitors; statins; ANTIPLATELET TREATMENT; HONG-KONG; ADHERENCE; MEDICATION; MORTALITY; OUTCOMES; PHARMACOTHERAPY; DETERMINANTS; NONADHERENCE; PREDICTORS;
D O I
10.3390/jcm9124109
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The discontinuation of recommended therapy after myocardial infarction predisposes patients to serious thrombotic complications. The aim of this study was a comprehensive analysis of permanent as well as short- and long-term discontinuation of pharmacotherapy, taking into consideration the basic groups of medications and nonadherence determinants in a one-year follow-up in post-myocardial infarction (MI) patients. Material and methods: The study was a single center cohort clinical trial with a one-year follow-up including 225 patients (73.3% men, 26.7% women) aged 62.9 +/- 11.9 years. In eight cases (3.6%), the follow-up duration was less than one year due to premature death. The following factors were analyzed: lack of post-discharge therapy initiation; short-term therapy discontinuation (<30 days); long-term therapy discontinuation (>= 30 days); and permanent cessation of therapy. The analysis of therapy discontinuation was performed based on prescription filling data. Results: Occupational activity (Odds Ratio (OR) 5.15; 95% Confidence interval (CI) 1.42-18.65; p = 0.013) and prior MI (OR 5.02; 95% CI 1.45-16.89; p = 0.009) were found to be independent predictors of a lack of post-discharge therapy initiation with P2Y(12) receptor inhibitors. We found no independent predictors of lack of post-discharge therapy initiation with other medications, whether analyzed separately or together. Age above 65 years (Hazard Ratio (HR)-1.59; 95% CI 1.15-2.19; p = 0.0049) and prior revascularization (HR-1.44; 95% CI 1.04-2.19; p = 0.0273) were identified as independent predictors of therapy discontinuation. Multilogistic regression analysis showed no independent predictors of the cessation of any of the medications as well as the permanent or temporary simultaneous discontinuation of all medications. Conclusions: The vast majority of post-MI patients discontinue, either temporarily or permanently, one of the essential medications within one year following myocardial infarction. The most likely medication class to be discontinued are statins. Older age and prior cardiac revascularization are independent determinants of therapy discontinuation.
引用
收藏
页码:1 / 13
页数:12
相关论文
共 50 条
  • [21] ANTITHROMBOTIC THERAPY AFTER MYOCARDIAL-INFARCTION
    CASTAIGNE, A
    ALBO, C
    VERSCHUREN, P
    PERCHET, H
    PHAM, I
    SAAL, JP
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1992, 85 (11): : 1703 - 1708
  • [22] Clopidogrel discontinuation after myocardial infarction and risk of thrombosis: a nationwide cohort study
    Charlot, Mette
    Nielsen, Lars Hougaard
    Lindhardsen, Jesper
    Ahlehoff, Ole
    Olsen, Anne-Marie S.
    Hansen, Morten Lock
    Hansen, Peter Riis
    Madsen, Jan Kyst
    Kober, Lars
    Gislason, Gunnar H.
    Torp-Pedersen, Christian
    EUROPEAN HEART JOURNAL, 2012, 33 (20) : 2527 - 2534
  • [23] Antithrombotic therapy after myocardial infarction.
    Becker, RC
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13): : 1019 - 1022
  • [24] Therapy of cardiogenic shock after myocardial infarction
    Ferrari, M.
    Figulla, H. R.
    INTERNIST, 2008, 49 (09): : 1047 - 1051
  • [25] MYOCARDIAL STANNING AFTER THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL INFARCTION
    Kenjaev, M.
    Kenjaev, S.
    Abdijalilova, S.
    Nizomov, A.
    ATHEROSCLEROSIS, 2016, 252 : E184 - E184
  • [28] Discontinuation of β-Blockers and the Risk of Myocardial Infarction in the Elderly
    Martina Teichert
    Peter A. G. M. de Smet
    Albert Hofman
    Jacqueline C. M. Witteman
    Bruno H. Ch. Stricker
    Drug Safety, 2007, 30 : 541 - 549
  • [29] Adjunctive therapy after reperfusion therapy in acute myocardial infarction
    Dries, DL
    Solomon, AJ
    Gersh, BJ
    CLINICAL CARDIOLOGY, 1998, 21 (06) : 379 - 386
  • [30] Discontinuation of β-blockers and the risk of myocardial infarction in the elderly
    Teichert, Martina
    de Smet, Peter A. G. M.
    Hofman, Albert
    Witteman, Jacqueline C. M.
    Stricker, Bruno H. Ch
    DRUG SAFETY, 2007, 30 (06) : 541 - 549